Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients
by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung
Updated on: May 09,2024
5
Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients
by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung
Updated on:May 09,2024
5